Owl Creek Wealth Partners »

Fate Therapeutics shares owned by Owl Creek Wealth Partners

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Owl Creek Wealth Partners from 13F filings

Historical chart of Owl Creek Wealth Partners investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Owl Creek Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Owl Creek Wealth Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.0k 4.2k 1.20

More positions owned by Owl Creek Wealth Partners

Dimensional Etf Trust Us Equity Market (DFUS)
Spdr Series Trust State Street Spd (SPTM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
J P Morgan Exchange Traded F Hedged Equity La (HELO)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
American Centy Etf Tr Us Eqt Etf (AVUS)
Vanguard Scottsdale Fds Vng Rus1000idx (VONE)
Apple (AAPL)
Ishares Tr Rus 1000 Etf (IWB)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Vanguard Index Fds Value Etf (VTV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for Owl Creek Wealth Partners

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Vanguard Capital Management
Vanguard Portfolio Management
Acadian Asset Management
Two Sigma Investments
Johnson & Johnson
AQR Capital Management
Geode Capital Management
Renaissance Technologies
State Street Corporation
UBS Group
Goldman Sachs Group
Tang Capital Management

View all funds holding Fate Therapeutics